Inventor · disambiguated record
David Edward Ormonde Knight
Also filed as: KNIGHT DAVID · KNIGHT DAVID EDWARD ORMONDE
7 granted patents·4 pending applications·11 citations·filing 2012–2023
79Inventor score
Top patents by PatentIndex Score
11 records- 0189US10287343B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted May 14, 2019·5 cites·32 claims
- 0287US10889640B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2019·Granted Jan 12, 2021·2 cites·10 claims
- 0386US10344081B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Jul 9, 2019·3 cites·38 claims
- 0483US10906966B2Tau-binding antibodiesUCB Biopharma SRL·Filed 2019·Granted Feb 2, 2021·1 cites·19 claims
- 0580US2023331833A1Tau-binding antibodiesUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 0678US2023416350A1Tau-binding antibodiesUCB Biopharma SRL·Filed 2023·Application pending·0 cites
- 0773US11746145B2Tau-binding antibodiesUCB Biopharma SRL·Filed 2020·Granted Sep 5, 2023·0 cites·18 claims
- 0871US11732034B2Tau-binding antibodiesUCB Biopharma SRL·Filed 2020·Granted Aug 22, 2023·0 cites·15 claims
- 0953US2020377578A1Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficileUCB BIOPHARMA SPRL·Filed 2020·Application pending·0 cites
- 1051US10752676B2Neutralising antibodies to the major exotoxins TCDA and TCDB of Clostridium difficileHUMPHREYS DAVID PAUL·Filed 2012·Granted Aug 25, 2020·0 cites·43 claims
- 1148US2023287095A1Humanized anti-emap ii therapeutic antibodiesALLINAIRE THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →